Abstract
Background: Ovarian cancer has become the commonest pelvic cancer all over the world. Because of its late detection it has a poor survival rate. Hence it is important to understand the clinicopathologic profile of this malignancy so that it will help in the early identification of the disease, histological typeand possible outcome.
Methods: This study was undertaken in SAT Hospital, Government Medical College, Thiruvananthapuram, for a period of one year. Women referred with a provisional diagnosis of ovarian tumour were recruited. Clinical features and investigation details were collected by a structured proforma. FIGO Staging was done after staging laparotomy and histological diagnosis was made.
Results: 58% of the ovarian tumours were primary in origin. 90% of the primary malignant tumours were surface epithelial tumours, of which 50% were serous cystadenocarcinomas and 30 % mucinous cystadenocarcinomas. Two thirds of patients with primary ovarian malignancy presented in late stages ie. Stage III or IV. Early presentation (stage 1 a) was seen in 28% of patients, majority of them were germ cell tumours. Ultrasound was able to detect evidence of malignancy in 100% of cases. CA 125 was elevated in all patients with surface epithelial tumours.
Conclusion: Majority of ovarian tumours were primary, of which 90% were surface epithelial tumours. Two thirds of patients presented in late stages. Ultrasound imaging along with tumour markers is a highly sensitive tool in the detection of ovarian malignancy preoperatively.
Keywords: ovarian malignancy, primary, histological types.
References
1. Qureshi F et al. Ovarian cancer:Changes in pattern at diagnosis and relative survival over the last three decades Am J Obstetr Gynaecol.;2003: 189:1120-1127
2. 1999 Compendium of selected publica-tions. ACOG Educational Bulletin No. 250. Washington, DC: American College of Obstetricians and Gynecologists; 1998:665-673
3. Hyo Young Jeoung, Han Song Choi et al The efficacy of sonographic morphology indexing and serum CA-125 for preoperative differentiation of malignant from benign ovarian tumors in patients after operation with ovarian tumors.J GynecolOncol. 2008 Dec; 19(4): 229–235.
4. Quin M Babb, P Brock et al. 2001 Cancer trends in England and Wales 1950 – 1999. Studies on medical and population subjects No.66. Stationary office London
5. Sorbe Bengt, Frankendal Bo, Veress Bela. Importance of histologic grading in the prognosis of epithelial ovarian carcin-oma. Obstet Gynecol. 1982;59: 576–82
6. Katsube Y, Berg JW, Silverberg SG. Epidemiologic pathology of ovarian tumors: A histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979. Int J GynecolPathol 1982; 1: 3-16.
7. Sorbe Bengt, Frankendal Bo, Veress Bela. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma. Obstet Gynecol. 1982;59:576–82
8. Clement PB, Young HR. Sternberg’s Diagnostic Surgical Pathology, 5th Edition. Ovarian Surface Epithelial-Stromal Tumours. Lippincott Williams & Wilkins; 2010. pp. 2272–306.
9. 1999 compendium of selected publications. ACOG Educational Bulletin No. 250. Washington, DC: American College of Obstetricians and Gynecologists; 1998:665-673
10. Wikborn C, Pettersson F, Silfvers-ward C, Moberg PJ. Symptoms and diagnostic difficulties in ovarian epithelial cancer. Int J Gynaecol Obstet.1993; 42:261-264.
11. Flam F, Einhorn N, Sjovall K. Symptom-atology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol.1988;27:53-57
12. Barbara A. Goff, MD; Lynn S. Mandel, PhDFrequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care Clinics JAMA. 2004;291(22):2705-2712. doi:10.1001/jama.291.22.2705
13. Stein SM et al. differentiation of benign and malignant adnexal masses: Relative value of grey scale colour Doppler and spectral Doppler sonography. Am J Roeentgenography. 1995 Feb:164 (2): 381-6
14. Munkarah A, Chatterjee M et al.update on ovarian cancer screening. Curr Opin Obstetr Gynaecol 2007 Feb 19(1) 22-26
National comprehensive cancer network (NCCN). Clinical practice guideline in oncology. Ovarian cancer version 3. 2012.
Corresponding Author
Anjali Devi. B
Associate Professor, Dept of O&G, SAT Hospital,
GMC, Thiruvananthapuram, Kerala, India
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v5i1.127
